Stay updated on Tislelizumab vs Sorafenib in Unresectable HCC Clinical Trial

Sign up to get notified when there's something new on the Tislelizumab vs Sorafenib in Unresectable HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tislelizumab vs Sorafenib in Unresectable HCC Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.6.3, indicating a minor platform/template update for the study record page.
    Difference
    0.0%
    Check dated 2026-07-03T23:23:43.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page's revision was updated from v3.6.0 to v3.6.2, signaling a backend/frontend update to the listing without modifying the study information.
    Difference
    0.0%
    Check dated 2026-06-27T00:12:46.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Recruitment status updated to 'No longer looking for participants' and new help sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment heading was updated and the page revision shows v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-12T16:28:46.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page’s revision badge shows v3.5.5, replacing the previous v3.5.4. This appears to be a minor, system-level update (software/documentation version) rather than a change to study content or functionality.
    Difference
    0.0%
    Check dated 2026-06-05T11:36:14.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.5.4 replaces the previous v3.5.3 label, signaling a backend or UI update unrelated to study details.
    Difference
    0.0%
    Check dated 2026-05-15T02:14:54.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The Taiwan location entry was updated from Taoyuan District, Taiwan, 33305 to Taoyuan, Taiwan, 33305, replacing the district designation with the city name while preserving the postal code.
    Difference
    0.0%
    Check dated 2026-05-07T22:10:27.000Z thumbnail image

Stay in the know with updates to Tislelizumab vs Sorafenib in Unresectable HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tislelizumab vs Sorafenib in Unresectable HCC Clinical Trial page.